The FDA granted orphan drug designation to deupirfenidone, also known as LYT-100, for treating patients with idiopathic pulmonary fibrosis, according to a press release from PureTech Health.The ...

Travis Corbitt's struggles to breathe led to his retirement and reliance on an oxygen tank.

Novel oral agent nerandomilast slowed lung capacity decline in patients with non-idiopathic pulmonary fibrosis (IPF) interstitial lung disease (ILD) with a progressive pulmonary fibrosis phenotype, ...

A woman in her late 20s presented with a 5-year history of progressive fatigue and generalised weakness. Examination revealed signs of premature ageing, anaemia, neuropathy and hepatosplenomegaly.

Please provide your email address to receive an email when new articles are posted on . Almost 90% of Americans are unaware of the symptoms that signal pulmonary fibrosis due to the disease’s rarity, ...

The proof-of-concept study also identified key metabolites that correlated with pulmonary fibrosis diagnosis and disease progression. Fibrotic interstitial lung disease is often diagnosed late because ...

Idiopathic pulmonary fibrosis stands as one of medicine’s most challenging respiratory conditions, gradually transforming healthy lung tissue into stiff, scarred material that severely compromises ...

This condition has been described by Michael J. Stephen in his 2021 book “Breath Taking” as the “most frustrating and disheartening of all the diseases in pulmonary medicine.” Over a frighteningly ...